Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (381-390 of 451) with videos related to

Pageof 46
Sort By:
Journal of Hepatology|June 26, 2018
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registryLuca Saverio Belli, Giovanni Perricone, Rene Adam, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
Long-term outcome in liver transplantation candidates with portopulmonary hypertensionLaurent Savale, Caroline Sattler, Audrey Coilly, et al.
Experimental and Molecular Pathology|September 7, 2015
Alcoholic liver disease: Clinical and translational researchManuela G Neuman, Stephen Malnick, Yaakov Maor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2020
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosisArmand Abergel, Tarik Asselah, Arianne Mallat, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 2020
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER RegistryFaouzi Saliba, Sébastien Dharancy, Ephrem Salamé, et al.
Clinics and Research in Hepatology and Gastroenterology|April 2, 2014
Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study)Jérôme Dumortier, Ephrem Salamé, Bruno Roche, et al.
The New England Journal of Medicine|November 11, 2011
Early liver transplantation for severe alcoholic hepatitisPhilippe Mathurin, Christophe Moreno, Didier Samuel, et al.
Journal of Hepatology|December 3, 2014
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failureRajiv Jalan, Marco Pavesi, Faouzi Saliba, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesisHong-Lei Weng, Yan Liu, Jia-Lin Chen, et al.
World Journal of Gastroenterology|May 17, 2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrenceAlice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, et al.
Pageof 46

Showing results (381-390 of 451) with videos related to

Sort By:
Pageof 46
Journal of Hepatology|June 26, 2018
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registryLuca Saverio Belli, Giovanni Perricone, Rene Adam, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
Long-term outcome in liver transplantation candidates with portopulmonary hypertensionLaurent Savale, Caroline Sattler, Audrey Coilly, et al.
Experimental and Molecular Pathology|September 7, 2015
Alcoholic liver disease: Clinical and translational researchManuela G Neuman, Stephen Malnick, Yaakov Maor, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2020
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosisArmand Abergel, Tarik Asselah, Arianne Mallat, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 2, 2020
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER RegistryFaouzi Saliba, Sébastien Dharancy, Ephrem Salamé, et al.
Clinics and Research in Hepatology and Gastroenterology|April 2, 2014
Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study)Jérôme Dumortier, Ephrem Salamé, Bruno Roche, et al.
The New England Journal of Medicine|November 11, 2011
Early liver transplantation for severe alcoholic hepatitisPhilippe Mathurin, Christophe Moreno, Didier Samuel, et al.
Journal of Hepatology|December 3, 2014
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failureRajiv Jalan, Marco Pavesi, Faouzi Saliba, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesisHong-Lei Weng, Yan Liu, Jia-Lin Chen, et al.
World Journal of Gastroenterology|May 17, 2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrenceAlice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, et al.
Pageof 46